BID | 15.93 | ASK | 16.71 | ||
Open | 16.27 | Previous Close | 16.36 | ||
Pre-Market | - | After-Market | 16.28 | ||
- - | - -% |
Target Price | 19.83 | Analyst Rating | Moderate Buy 2.22 | |
Potential % | 21.81 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★ 40.75 | |
Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★+ 41.22 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
Price Range Ratio 52W % | 38.10 | Earnings Rating | — | |
Market Cap | 5.71B | Earnings Date | 1st Nov 2023 | |
Alpha | 0.00 | Standard Deviation | 0.07 | |
Beta | 0.22 |
Today's Price Range 16.1216.49 | 52W Range 12.7921.95 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -4.05% | ||
1 Month | -8.86% | ||
3 Months | -19.73% | ||
6 Months | -3.65% | ||
1 Year | 0.74% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | 0.79 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | 0.58 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | 0.54 | |||
Return on invested Capital Q | 0.02 | |||
Return on invested Capital Y | 1.89 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 4.20 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
110.00 | ||||
0.83 | ||||
1.98 | ||||
16.10 | ||||
98.20 | ||||
1.35 | ||||
22.36 | ||||
19.23 | ||||
7.38B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.80 | ||||
1.60 | ||||
0.26 | ||||
0.36 | ||||
2.60 | ||||
Leverage Ratio | 1.60 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
59.90 | ||||
7.60 | ||||
17.90 | ||||
- | ||||
0.54 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.86B | ||||
8.18 | ||||
-0.28 | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 0.16 | 0.18 | 12.50 |
Q01 2023 | 0.14 | 0.10 | -28.57 |
Q04 2022 | 0.22 | 0.23 | 4.55 |
Q03 2022 | 0.23 | 0.31 | 34.78 |
Q02 2022 | 0.20 | 0.29 | 45.00 |
Q01 2022 | - | 0.06 | - |
- | - | - | - |
- | - | - | - |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 1st Nov 2023 |
Estimated EPS Next Report | 0.17 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 584.42K |
Shares Outstanding | 350.70K |
Shares Float | 40.16M |
Trades Count | 5.87K |
Dollar Volume | 9.51M |
Avg. Volume | 477.33K |
Avg. Weekly Volume | 507.05K |
Avg. Monthly Volume | 458.57K |
Avg. Quarterly Volume | 466.36K |
Bausch + Lomb Corporation (NYSE: BLCO) stock closed at 16.36 per share at the end of the most recent trading day (a -3.48% change compared to the prior day closing price) with a volume of 860.31K shares and market capitalization of 5.71B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 19600 people. Bausch + Lomb Corporation CEO is .
The one-year performance of Bausch + Lomb Corporation stock is 0.74%, while year-to-date (YTD) performance is 5.48%. BLCO stock has a five-year performance of %. Its 52-week range is between 12.79 and 21.95, which gives BLCO stock a 52-week price range ratio of 38.10%
Bausch + Lomb Corporation currently has a PE ratio of 110.00, a price-to-book (PB) ratio of 0.83, a price-to-sale (PS) ratio of 1.98, a price to cashflow ratio of 16.10, a PEG ratio of -, a ROA of 0.58%, a ROC of 0.54% and a ROE of 0.79%. The company’s profit margin is 0.54%, its EBITDA margin is 17.90%, and its revenue ttm is $2.86 Billion , which makes it $8.18 revenue per share.
Of the last four earnings reports from Bausch + Lomb Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.17 for the next earnings report. Bausch + Lomb Corporation’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Bausch + Lomb Corporation is Moderate Buy (2.22), with a target price of $19.83, which is +21.81% compared to the current price. The earnings rating for Bausch + Lomb Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bausch + Lomb Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Bausch + Lomb Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 67.03, ATR14 : 0.46, CCI20 : -167.69, Chaikin Money Flow : -0.12, MACD : -0.45, Money Flow Index : 43.47, ROC : -7.67, RSI : 29.53, STOCH (14,3) : 12.17, STOCH RSI : 0.00, UO : 41.25, Williams %R : -87.83), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bausch + Lomb Corporation in the last 12-months were:
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.
CEO:
Telephone: +1 905 695-7700
Address: 520 Applewood Crescent, Vaughan L4K 4B4, ON, CA
Number of employees: 19 600
Fri, 29 Sep 2023 14:05 GMT Novartis completes divestment of front of eye ophthalmology assets
- TipRanks. All rights reserved.Fri, 29 Sep 2023 14:02 GMT Bausch + Lomb completes acquisition of Xiidra from Novartis
- TipRanks. All rights reserved.Mon, 03 Jul 2023 10:05 GMT Bausch + Lomb Corporation (BLCO) Receives a Hold from Barclays
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.